Tom B - Search Results

1

Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.

van Esch JH, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JM, de Bruijn RJ, de Vries R, Danser AH. van Esch JH, et al. Among authors: tom b. Hypertension. 2005 Jan;45(1):120-5. doi: 10.1161/01.HYP.0000151323.93372.f5. Epub 2004 Dec 6. Hypertension. 2005. PMID: 15583077

2

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

Tom B, Dendorfer A, Danser AH. Tom B, et al. Int J Biochem Cell Biol. 2003 Jun;35(6):792-801. doi: 10.1016/s1357-2725(02)00273-x. Int J Biochem Cell Biol. 2003. PMID: 12676166 Review.

3

Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.

Schuijt MP, Tom B, de Vries R, Saxena PR, Sluiter W, van Kats JP, Danser AH. Schuijt MP, et al. Among authors: tom b. J Hypertens. 2003 Dec;21(12):2335-44. doi: 10.1097/00004872-200312000-00023. J Hypertens. 2003. PMID: 14654755

4

Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s).

Batenburg WW, Tom B, Schuijt MP, Danser AH. Batenburg WW, et al. Among authors: tom b. Vascul Pharmacol. 2005 Feb;42(3):109-18. doi: 10.1016/j.vph.2005.01.005. Vascul Pharmacol. 2005. PMID: 15792928 Review.

5

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition.

Danser AH, Tom B, de Vries R, Saxena PR. Danser AH, et al. Among authors: tom b. Br J Pharmacol. 2000 Sep;131(2):195-202. doi: 10.1038/sj.bjp.0703555. Br J Pharmacol. 2000. PMID: 10991911 Free PMC article.

6

Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxide.

Tom B, de Vries R, Saxena PR, Danser AH. Tom B, et al. J Hypertens. 2001 Jul;19(7):1289-93. doi: 10.1097/00004872-200107000-00014. J Hypertens. 2001. PMID: 11446719

7

Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.

Tom B, de Vries R, Saxena PR, Danser AH. Tom B, et al. Hypertension. 2001 Jul;38(1):95-9. doi: 10.1161/01.hyp.38.1.95. Hypertension. 2001. PMID: 11463767 Free article.

8

Bradykinin potentiation by ACE inhibitors: a matter of metabolism.

Tom B, Dendorfer A, de Vries R, Saxena PR, Jan Danser AH. Tom B, et al. Br J Pharmacol. 2002 Sep;137(2):276-84. doi: 10.1038/sj.bjp.0704862. Br J Pharmacol. 2002. PMID: 12208785 Free PMC article.

9

ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?

Tom B, Garrelds IM, Scalbert E, Stegmann AP, Boomsma F, Saxena PR, Danser AH. Tom B, et al. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):251-6. doi: 10.1161/01.atv.0000051875.41849.25. Arterioscler Thromb Vasc Biol. 2003. PMID: 12588767

10

Inotropic effects of endothelin compared to noradrenaline in porcine myocardial trabeculae.

Saetrum Opgaard O, Tom B, de Vries R, Saxena PR, Edvinsson L. Saetrum Opgaard O, et al. Among authors: tom b. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S172-5. doi: 10.1097/00005344-200036051-00053. J Cardiovasc Pharmacol. 2000. PMID: 11078369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters